Article
Genomic ascertainment to quantify prevalence and cancer risk in adults with pathogenic and likely pathogenic germline variants in RASopathy genes
2024-10-11
Abstract excerpt
<h4>Purpose</h4> Genomic ascertainment of electronic health record-linked exome data in two large biobanks was used to quantify germline pathogenic/likely pathogenic (P/LP) variant prevalence, cancer prevalence, and survival in adults with non- NF1 RAS/mitogen-activated protein kinase genes (RASopathies). <h4>Patients and Methods</h4> Germline RASopathy variants were examined from adult participants in UK Biobank...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ea7a5fbf-d494-5b82-b7b6-170a05b68e34
- DOI
- 10.1101/2024.10.09.24314324
